アルブミン融合タンパク質 - Human Genome Sciences, Inc.

Title:

アルブミン融合タンパク質

Document Type and Number:

Japanese Patent JP5856131

Kind Code:

B2

Abstract:

The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Inventors:

Craig A. Rosen
Adam Bell
Paul A. Moore
Young Shi
David LaFruir
Jason Bock
Michael wake lair
William A. Hazeltine
Douglas Bee Woods
Mani Sabramanian

Application Number:

JP2013233069A

Publication Date:

February 09, 2016

Filing Date:

November 11, 2013

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Human Genome Sciences, Inc.

International Classes:

C12N15/09; A61K38/00; A61K38/46; A61K47/48; A61K49/00; A61K51/00; A61P25/00; A61P25/28; A61P25/36; C07K14/76; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02

Domestic Patent References:

JP2006522611A
JP2004535155A

Foreign References:

WO2007021494A1
US20060253913
US20040121970

Other References:

J. pharmacology and experimental therapeutics,2002年,Vol.302. No.2,p.751-758.
Pharmaceutical Research,2002年,Vol.19, No.11,p.1720-1729
European Journal of Pharmacology,2002年,Vol.456,p.149-158
The Journal of Pharmacology and Experimental Therapeutics,2002年,Vol.303, No.2,p.540-548

Attorney, Agent or Firm:

Mitsuo Tanaka
Hiroshi Yamazaki
Kenji Tomita

Previous Patent: ２，３，３，３−テトラフルオロプロペンを生成するための総合プロセス

Next Patent: TYPEWRITER INPUT EQUIPMENT